Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by MediWound Ltd. MediWound Reports First Quarter 2024 Financial Results and Provides Company Update May 29, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Report First Quarter 2024 Financial Results May 22, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences April 25, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update March 21, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Report Fourth Quarter and Full Year 2023 Financial Results March 14, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study February 12, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Participate in Two Upcoming Investor Conferences February 05, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns January 09, 2024 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army December 28, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads December 21, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update November 21, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer November 21, 2023 From MediWound Ltd. Via GlobeNewswire Tickers ENLV MDWD MediWound to Report Third Quarter 2023 Financial Results November 14, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients November 13, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe November 08, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Collaboration with 3M on EscharEx® Phase III Study October 11, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MMM MediWound Deploys NexoBrid® for Emergency Supply October 09, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults September 21, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound’s NexoBrid® Highlighted in 20 Oral and Poster Presentations at the 20th European Burns Association Congress September 11, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Participate in Fireside Chat at H.C. Wainwright 25th Annual Global Investment Conference September 05, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update August 15, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study August 15, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study August 15, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MDXG MediWound to Report Second Quarter 2023 Financial Results August 07, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Commercial Launch of NexoBrid® in Japan August 01, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Announces Positive Results in Its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma July 10, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on EscharEx Phase III Study Design July 03, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023 June 14, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound Reports First Quarter 2023 Financial Results and Provides a Company Update May 30, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD MediWound to Report First Quarter 2023 Financial Results May 12, 2023 From MediWound Ltd. Via GlobeNewswire Tickers MDWD Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.